Business Wire

SIAL Paris 2026: Food Sovereignty, AI, Personalised Nutrition… Three Major Debates to Shape the Future of Food

14.10.2026 09:35:00 CEST | Business Wire | Press Release

Share

More than just a major business event, SIAL Paris is also a forum for reflection, analysis and inspiration for the entire food sector. Over five days, several stages will bring together leaders, experts, manufacturers, retailers, researchers and entrepreneurs to analyse the sector’s transformations and, above all, to identify concrete courses of action. Food sovereignty, artificial intelligence, geopolitics, new consumption models, personalised nutrition and the transformation of the value chain: the 2026 edition offers a particularly rich programme, featuring conferences, keynote speeches, round-table discussions, pitches and case studies.

SIAL Summits: three major events to understand today and prepare for tomorrow

At the heart of this programme, the SIAL Summits, held in Hall 5A, offer three premium 2½-hour sessions dedicated to the strategic challenges reshaping the agri-food industry. Designed as genuine platforms for discussion and reflection, they will bring together experts and decision-makers to share perspectives and explore practical solutions.

  • ‘Feeding a world under strain’
    Monday 19 October, from 10.30 am to 1 pm
    How must the global food industry reorganise itself in the face of current environmental and geopolitical challenges to secure its future?
    The Summit will open with Bertrand Piccard, founder of the Solar Impulse Foundation, delivering a keynote speech entitled ‘Solutions to change the world’, followed by two panel discussions featuring, amongst others, Capucine Laurent (The Shift Project), Bertrand Swiderski (Carrefour), Tania Cavassini (Swiss Embassy in France), Sandrine Doppler (L’Effet Doppler) and geographer Pierre Raffard.
  • “Food Intelligence: redefining the value chain”
    Monday 19 October, from 2.00 pm to 4.30 pm
    How are technology, data, platforms and AI redefining the rules of the game for players in the agri-food sector?
    Speakers include: Maxime Marembaud (Sodexo), François Deprey (SprintProject), Jean-Gabriel Mollard (SIAL Paris), Olivier Gibert (Carrefour), Arnaud Girard (Google), Cyrille Charnier (Verallia) and Simon Bussy (Califrais).
  • ‘The era of personalised food’
    Tuesday 20 October, from 2.00 pm to 4.30 pm
    How are trends transforming the way we eat, and how are science and technology reinventing personalised nutrition?
    Candice Alvarez (NellyRodi)
    will open the session, followed by Émilie Félix (WAYO – Le Goût du vivant), Serge Fourcade (Thalazur), Grégory Dubourg (Nutrikéo x ProtéinesXTC), Céline Santos Nunes (Compass Group France), Jacques Gustin (Lesaffre) and Sébastien Massart (Dassault Systèmes).

Would you like to attend one of these summits?
Please let us know by emailing sial@14septembre.com so that the team can confirm your attendance (limited capacity)

About SIAL Paris

Since 1964, SIAL Paris has been the world’s largest trade fair dedicated to the agri-food industry. Held every two years, it brings together professionals and key players in the sector to explore trends, showcase innovations and develop business opportunities on an international scale

View source version on businesswire.com: https://www.businesswire.com/news/home/20261013247625/en/

Contacts

Press
Head of International Communications
Juliette.marzynski@comexposium.com
sial@14septembre.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Spotlight Medical Announces Successful Independent Evaluation of Its Digital Slide-Based Test for Assessing Recurrence Risk in Early Breast Cancer22.10.2026 12:18:00 CEST | Press Release

Spotlight Medical, a company developing AI-powered prognostic tests in oncology, today announced results from an independent evaluation of myStage Dx, its CE-IVDR-marked test for assessing recurrence risk in patients with hormone receptor-positive, HER2-negative early breast cancer. The study was conducted by researchers at Karolinska Institutet in Sweden. Independent, Blinded Evaluation Using Phase III Trial Data The study used data from 620 patients enrolled in PANTHER, an international randomized phase III trial comparing dose-dense with standard chemotherapy. myStage Dxpredictions were generated blinded to clinical outcomes. Researchers at Karolinska Institutet linked the predictions to patient outcomes and independently assessed prognostic performance according to a prespecified protocol and statistical analysis plan. Within this clinically high-risk population, myStage Dx identified two groups with markedly different long-term outcomes. The Low Risk group comprised 23.5% of patie

Zoomtopia: Zoom lanserar nya AI-funktioner22.10.2026 12:14:00 CEST | Pressmeddelande

Zoom vill korta vägen från mötesbeslut till genomfört arbete. På kundkonferensen Zoomtopia presenterar företaget Unified Context Layer – ett gemensamt informationslager som kopplar ihop samtal, dokument och data så att AI kan förstå sammanhanget och hjälpa till med nästa steg. Samtidigt lanseras flera nya AI-produkter och funktioner som ska göra det enklare att omsätta diskussioner och beslut i handling. Detta pressmeddelande använder multimedia. Se den fullständiga versionen här: https://www.businesswire.com/news/home/20261021741529/sv/ I möten och samtal fattas viktiga beslut och företag får värdefulla insikter om sina kunder. Men en kunddialog kan börja i ett möte, fortsätta på telefon och sedan övergå i en chatt. När information sprids mellan olika verktyg blir det svårt för både medarbetare och AI-agenter att få en samlad bild av vad som har sagts och beslutats. Resultatet blir att värdefull tid går åt till att ta reda på vad som har sagts och beslutats och vad som behöver göras h

TACTICA AI and NVIDIA Collaborate to Scale Agentic AI Capabilities with NVIDIA Nemotron22.10.2026 12:01:00 CEST | Press Release

TACTICAAI, an operational decision-intelligence company, today announced a collaboration with NVIDIA to advance and scale the deployment of agentic AI capabilities. The companies will work together to integrate and optimize NVIDIA Nemotron models within TACTICAAI’s multi-intelligence platform, with a focus on expanding these capabilities and supporting deployment with major customers internationally. The collaboration was announced at NVIDIA GTC Berlin. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022054475/en/ TACTICA AI and NVIDIA Collaborate to Scale Agentic AI Capabilities with NVIDIA Nemotron (Graphic: AETOSWire) The collaboration with NVIDIA builds on the company’s existing technology, integrating selected NVIDIA AI models and tools to further enhance capabilities across advanced reasoning, autonomous analysis and video intelligence. The integration allows TACTICAAI to draw on NVIDIA’s AI ecosystem while maintaini

BeOne Medicines to Announce Third Quarter 2026 Financial Results on November 522.10.2026 12:01:00 CEST | Press Release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its third quarter 2026 financial results on Thursday, November 5, 2026, before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com.To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has

Bregal Milestone Backs Nethive With Majority Growth Investment and JoyComm Acquisition22.10.2026 10:00:00 CEST | Press Release

Bregal Milestone, a leading European software growth private equity firm, today announced a majority growth investment in Nethive S.p.A. (“Nethive” or the “Company”), a leading Italian cybersecurity services and software provider. Alongside its investment in Nethive, Bregal Milestone has also backed Nethive’s acquisition of IT security specialist Joy Comm S.r.l. (“JoyComm”). Founded in 2014 by Alessandro Bellato and Diego Rocco, Nethive has become a trusted cybersecurity partner to blue-chip enterprises, SMEs, and public-sector organizations across Italy. Its platform spans managed security services, professional services and technology resale, helping organizations protect critical infrastructure and networks, strengthen cyber resilience and reduce operational complexity. Nethive combines deep technical expertise with 24/7 monitoring, threat detection and response, risk and vulnerability management, infrastructure protection and specialist consultancy. The Company serves more than 250

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye